FDA 510(k)

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT

N.º K: K231214 · 2023-10-27

Fecha de decisión2023-10-27

Código de productoLFY

Comité asesorMI

DecisiónSubstantially Equivalent

Resumen del dispositivo

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT is the device name listed in this FDA 510(k) record. The listed applicant is DiaSorin, Inc.. It received FDA 510(k) clearance on 2023-10-27 under 510(k) number K231214. The device is classified under product code LFY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the LIAISON VZV IgG HT, LIAISON Control VZV IgG HT?

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT is a medical device that received FDA 510(k) clearance on 2023-10-27. The listed applicant is DiaSorin, Inc.. The 510(k) number is K231214.

When did LIAISON VZV IgG HT, LIAISON Control VZV IgG HT receive FDA 510(k) clearance?

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT received FDA 510(k) clearance on 2023-10-27, under 510(k) number K231214.

Who is the listed applicant for LIAISON VZV IgG HT, LIAISON Control VZV IgG HT?

The FDA 510(k) record lists DiaSorin, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIAISON VZV IgG HT, LIAISON Control VZV IgG HT?

The FDA product code for LIAISON VZV IgG HT, LIAISON Control VZV IgG HT is LFY.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a DiaSorin, Inc. como solicitante

K260770LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX K223403LIAISON Anti-HAV; LIAISON XS K213858LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus K213936LIAISON MeMed BV, LIAISON MeMed BV Control Set K193650LIAISON Ferritin K202574LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody Plus

Ver todos los 25 dispositivos →

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.